In order to better understand the IL-17 changes upon glucocorticoid therapy in inflammatory immune response of SLE, we evaluated the correlation of IL-17 plasma levels with IFN-γ and IL-10 expression levels, which were reported previously (19). The gene discussed is IL10; the disease is systemic lupus erythematosus.